{"id":340580,"date":"2025-08-20T11:55:52","date_gmt":"2025-08-20T11:55:52","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-amgen\/"},"modified":"2025-08-20T11:55:52","modified_gmt":"2025-08-20T11:55:52","slug":"how-to-buy-amgen","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/","title":{"rendered":"Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Amgen Inc. (AMGN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-340580","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amgen Inc. (AMGN) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amgen Inc. (AMGN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Amgen Inc. (AMGN) hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, 2025-2030 tahminleri ve biyoteknoloji sekt\u00f6r\u00fc f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Amgen Inc. (AMGN) hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, 2025-2030 tahminleri ve biyoteknoloji sekt\u00f6r\u00fc f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini \u00f6\u011frenin."},"intro":"Portf\u00f6y\u00fcn\u00fcze bir biyoteknoloji devi eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Amgen Inc. (AMGN), 45 y\u0131ll\u0131k yenilik ge\u00e7mi\u015fiyle ila\u00e7 end\u00fcstrisinin en k\u00f6kl\u00fc oyuncular\u0131ndan biridir. Bu sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil\u2014b\u00fct\u00fcn biyoteknoloji sekt\u00f6r\u00fcn\u00fc tan\u0131mlamaya yard\u0131mc\u0131 olmu\u015f bir \u015firkettir. G\u00fcncel fiyatland\u0131rmadan uzun vadeli b\u00fcy\u00fcme potansiyeline kadar her \u015feyi detayland\u0131raca\u011f\u0131z ve 2025 y\u0131l\u0131nda ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 alman\u0131z i\u00e7in gereken i\u00e7g\u00f6r\u00fcleri sunaca\u011f\u0131z.","intro_source":{"label":"Intro","type":"text","formatted_value":"Portf\u00f6y\u00fcn\u00fcze bir biyoteknoloji devi eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Amgen Inc. (AMGN), 45 y\u0131ll\u0131k yenilik ge\u00e7mi\u015fiyle ila\u00e7 end\u00fcstrisinin en k\u00f6kl\u00fc oyuncular\u0131ndan biridir. Bu sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil\u2014b\u00fct\u00fcn biyoteknoloji sekt\u00f6r\u00fcn\u00fc tan\u0131mlamaya yard\u0131mc\u0131 olmu\u015f bir \u015firkettir. G\u00fcncel fiyatland\u0131rmadan uzun vadeli b\u00fcy\u00fcme potansiyeline kadar her \u015feyi detayland\u0131raca\u011f\u0131z ve 2025 y\u0131l\u0131nda ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 alman\u0131z i\u00e7in gereken i\u00e7g\u00f6r\u00fcleri sunaca\u011f\u0131z."},"body_html":"<h2>\ud83d\udcc8 Amgen Hisse Analizi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla Amgen Inc. (AMGN), NASDAQ borsas\u0131nda <strong>295,55 $<\/strong> seviyesinden i\u015flem g\u00f6rmektedir. Bu fiyat, hisse senedinin kazan\u00e7 sonras\u0131 volatiliteyi y\u00f6netirken g\u00fc\u00e7l\u00fc temel performans\u0131n\u0131 s\u00fcrd\u00fcrd\u00fc\u011f\u00fc kritik bir an\u0131 temsil ediyor.<\/p> <p><strong>Takviminize not edin: 29 Ekim 2025 kesinlikle kritik.<\/strong> Amgen, bu tarihte piyasa kapan\u0131\u015f\u0131ndan sonra 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar deneyimli yat\u0131r\u0131mc\u0131lar\u0131n yararlanabilece\u011fi \u00f6nemli fiyat hareketleri yaratm\u0131\u015ft\u0131r.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 AMGN Hissesini Nas\u0131l Etkiler?<\/h3> <p>5 A\u011fustos 2025'teki en son kazan\u00e7 a\u00e7\u0131klamas\u0131 m\u00fckemmel bir \u00f6rnek sunuyor. Hisse ba\u015f\u0131na 6,02 $ kazan\u00e7 (5,28 $ konsens\u00fcse kar\u015f\u0131) ve %9,4 gelir art\u0131\u015f\u0131 ile 9,18 milyar $ gelir elde edilmesine ra\u011fmen, hisse senedi a\u00e7\u0131klama sonras\u0131 <strong>%5,1<\/strong> d\u00fc\u015ft\u00fc. Bu, g\u00fc\u00e7l\u00fc temel performans\u0131n bile pozitif fiyat hareketini garanti etmedi\u011fini; piyasa duyarl\u0131l\u0131\u011f\u0131 ve rehberli\u011fin genellikle daha b\u00fcy\u00fck rol oynad\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p> <p>Tarihsel kazan\u00e7 tepkileri bize \u015funlar\u0131 s\u00f6yl\u00fcyor:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Beklenen Hareket<\/th><th>Ger\u00e7ekle\u015fen Hareket<\/th><th>Sonu\u00e7<\/th><\/tr> <\/thead> <tbody> <tr><td>5 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>\u00b1%4,6<\/td><td>-%5,1<\/td><td>Tahminleri a\u015ft\u0131 ama d\u00fc\u015ft\u00fc<\/td><\/tr> <tr><td>\u00d6nceki \u00c7eyrek<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>Yok<\/td><td>%17,79 s\u00fcrpriz<\/td><td>\u00d6nemli pozitif tepki<\/td><\/tr> <tr><td>Tarihsel Ortalama<\/td><td>\u00c7e\u015fitli<\/td><td>\u00b1%4-5<\/td><td>\u00c7ok de\u011fi\u015fken<\/td><td>Temellere ra\u011fmen \u00f6ng\u00f6r\u00fclemez<\/td><\/tr> <\/tbody> <\/table> <p>Model, Amgen'in kazan\u00e7 tepkilerinin tahmin edilmesinin zorlu\u011funu g\u00f6steriyor. Opsiyon piyasalar\u0131 genellikle %4-5 civar\u0131nda hareket fiyatlar, ancak ger\u00e7ek sonu\u00e7lar her iki y\u00f6nde de \u00f6nemli sapmalar g\u00f6sterebilir.<\/p> <h3>6 Ayl\u0131k Fiyat Seyri ve Trend Analizi<\/h3> <p>Amgen, son alt\u0131 ayda \u00f6nemli volatilite ya\u015fad\u0131 ve vah\u015fi dalgalanmalara ra\u011fmen toplamda <strong>%5,51 kazan\u00e7<\/strong> sa\u011flad\u0131. Hisse 6 Ocak 2025'te <strong>257,05 $<\/strong> dip seviyesine ula\u015ft\u0131, ard\u0131ndan 10 Mart 2025'te <strong>335,88 $<\/strong> zirveye \u00e7\u0131kt\u0131\u2014dipten zirveye <strong>%30,7'lik<\/strong> ola\u011fan\u00fcst\u00fc bir dalgalanma.<\/p> <p>\u015eu anki 295,55 $ fiyat\u0131 hisseyi konumland\u0131r\u0131yor:<\/p> <ul> <li><strong>%12,9 alt\u0131nda<\/strong> alt\u0131 ayl\u0131k zirvesinin<\/li> <li><strong>%13,9 \u00fczerinde<\/strong> alt\u0131 ayl\u0131k dip seviyesinin<\/li> <li>52 haftal\u0131k ortalama olan 296,54 $ seviyesinin biraz alt\u0131nda<\/li> <\/ul> <p>Son i\u015flem paterni, g\u00fc\u00e7l\u00fc \u00e7eyrek sonu\u00e7lar\u0131na ra\u011fmen devam eden belirsizli\u011fi g\u00f6stererek fiyatlar\u0131n A\u011fustos ortas\u0131nda 289-296 $ aras\u0131nda hareket etti\u011fini ortaya koyuyor.<\/p> <h3>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h3> <p>Mevcut analist konsens\u00fcs\u00fc ve \u00fcr\u00fcn hatt\u0131 geli\u015fmelerine dayanarak beklentiler \u015funlard\u0131r:<\/p> <p><strong>2025 Y\u0131l Sonu Hedefi: 340-345 $<\/strong> (mevcut fiyata g\u00f6re %15-17 y\u00fckseli\u015f)<br> Analistler, 2025 ortalama fiyat hedefini yakla\u015f\u0131k 340,02 $ olarak \u00f6ng\u00f6r\u00fcyor, en y\u00fcksek hedefler ise 385,98 $ seviyesinde. G\u00fc\u00e7l\u00fc 2. \u00e7eyrek sonu\u00e7lar\u0131 ve 35-36 milyar $ gelir i\u00e7in y\u00fckseltilmi\u015f tam y\u0131l rehberli\u011fi bu iyimser g\u00f6r\u00fcn\u00fcm\u00fc destekliyor.<\/p> <p><strong>2026 Tahmini: 360-380 $<\/strong> (\u0131l\u0131ml\u0131 b\u00fcy\u00fcme devam ediyor)<br> MariTide obezite ilac\u0131 Faz 3 denemelerinde ilerledik\u00e7e ve yeni endikasyonlar kabul g\u00f6rd\u00fck\u00e7e istikrarl\u0131 bir de\u011fer art\u0131\u015f\u0131 bekleniyor.<\/p> <p><strong>2028 Projeksiyonu: 380-420 $<\/strong> (\u00dcr\u00fcn hatt\u0131 olgunla\u015fmas\u0131 kar\u015f\u0131l\u0131\u011f\u0131n\u0131 veriyor)<br> 2028 y\u0131l\u0131na kadar bir\u00e7ok \u00fcr\u00fcn ticarile\u015fmi\u015f olacak ve bu, miras \u00fcr\u00fcnlerin \u00f6tesinde s\u00fcrd\u00fcr\u00fclebilir gelir art\u0131\u015f\u0131 sa\u011flayacak.<\/p> <p><strong>2030 Uzun Vadeli G\u00f6r\u00fcn\u00fcm: 390-450 $<\/strong> (S\u00fcrd\u00fcr\u00fclebilir b\u00fcy\u00fcme e\u011filimi)<br> Uzun vadeli modeller, Amgen'in 2030'da 394 $ ve \u00fczeri seviyelere ula\u015faca\u011f\u0131n\u0131 \u00f6ng\u00f6r\u00fcyor; bu muhafazakar ama istikrarl\u0131 bir de\u011fer art\u0131\u015f\u0131n\u0131 temsil ediyor.<\/p> <p><strong>Sonu\u00e7: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in AL, k\u0131sa vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in BEKLE.<\/strong> Mevcut d\u00fc\u015f\u00fc\u015f, 2-3 y\u0131ll\u0131k ufku olanlar i\u00e7in cazip bir giri\u015f noktas\u0131 sunuyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2> <h3>Her Yat\u0131r\u0131mc\u0131n\u0131n Dikkate Almas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Patent U\u00e7urumu Endi\u015feleri:<\/strong> Amgen'in en b\u00fcy\u00fck \u00fc\u00e7 \u00fcr\u00fcn\u00fc gelirlerin %55'ini olu\u015fturuyor ve bu \u00fcr\u00fcnlerin patentleri sona ermek \u00fczere, bu da sat\u0131\u015flar\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir. T\u00fcm ila\u00e7 sekt\u00f6r\u00fc, 2030'a kadar patent sona ermesi nedeniyle 300 milyar $ \u00fczerinde sat\u0131\u015f riskiyle kar\u015f\u0131 kar\u015f\u0131ya.<\/li> <li><strong>Reg\u00fclasyon Zorluklar\u0131:<\/strong> ABD Enflasyon Azaltma Yasas\u0131, 2039'a kadar ila\u00e7 gelirlerinde %31 azalma ve 135 daha az yeni ila\u00e7 onay\u0131 \u00f6ng\u00f6r\u00fcyor. Bu, ila\u00e7 geli\u015ftirme ekonomisini temelden de\u011fi\u015ftiriyor.<\/li> <li><strong>Rekabet Bask\u0131s\u0131:<\/strong> Ya\u015fam bilimleri y\u00f6neticilerinin %37'si, 2025 i\u00e7in jenerik ve biyobenzer rekabetini en b\u00fcy\u00fck endi\u015fe olarak g\u00f6r\u00fcyor. Amgen'in biyolojik \u00fcr\u00fcnleri, patentlerin sona ermesiyle artan rekabetle kar\u015f\u0131 kar\u015f\u0131ya.<\/li> <li><strong>Ekonomik K\u0131r\u0131lganl\u0131k:<\/strong> 2008 benzeri ciddi bir ekonomik kriz, Amgen'in rekabet avantajlar\u0131na ra\u011fmen gelir ve k\u00e2rlar\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir.<\/li> <\/ul> <h3>2025 B\u00fcy\u00fcmesi \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>MariTide At\u0131l\u0131m\u0131:<\/strong> Obezite ilac\u0131, kat\u0131l\u0131mc\u0131lar\u0131n %20'ye varan kilo kayb\u0131 ya\u015fad\u0131\u011f\u0131n\u0131 ve 52 haftada plato yapmad\u0131\u011f\u0131n\u0131 g\u00f6sterdi; ayl\u0131k dozlama potansiyeli tedavi devaml\u0131l\u0131\u011f\u0131n\u0131 devrim niteli\u011finde de\u011fi\u015ftirebilir.<\/li> <li><strong>G\u00fc\u00e7l\u00fc 2. \u00c7eyrek Performans\u0131:<\/strong> Toplam gelirler %9 artarak 9,2 milyar $ oldu, \u00fcr\u00fcn sat\u0131\u015flar\u0131 %9 ve hacim b\u00fcy\u00fcmesi %13 artt\u0131. On be\u015f \u00fcr\u00fcn \u00e7ift haneli sat\u0131\u015f b\u00fcy\u00fcmesi sa\u011flad\u0131.<\/li> <li><strong>\u00c7oklu Onaylar:<\/strong> IMDELLTRA ABD'de ilk onay\u0131n\u0131 ald\u0131 ve \u00f6l\u00fcm riskini %40 azaltt\u0131, TEPEZZA Avrupa onay\u0131 ald\u0131, UPLIZNA y\u0131ll\u0131k %91 b\u00fcy\u00fcme g\u00f6sterdi.<\/li> <li><strong>Y\u00fckseltilmi\u015f Rehberlik:<\/strong> Y\u00f6netim, 2025 tam y\u0131l gelir rehberli\u011fini 35-36 milyar $ ve GAAP d\u0131\u015f\u0131 hisse ba\u015f\u0131 kazanc\u0131 20,21-21,30 $ olarak art\u0131rd\u0131, bu da uygulama konusundaki g\u00fcveni g\u00f6steriyor.<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ul> <li><strong>Stratejik Giri\u015f Noktalar\u0131:<\/strong> Dolar maliyeti ortalamas\u0131 kullan\u0131n\u2014m\u00fckemmel giri\u015f zaman\u0131n\u0131 yakalamaya \u00e7al\u0131\u015fmak yerine haftal\u0131k sabit miktarlarda yat\u0131r\u0131m yap\u0131n. Amgen'in volatilitesi zamanlamay\u0131 \u00e7ok zorla\u015ft\u0131r\u0131yor.<\/li> <li><strong>Kazan\u00e7 Oynunu Planlay\u0131n:<\/strong> 29 Ekim kazan\u00e7lar\u0131 i\u00e7in uyar\u0131lar kurun. Tarihsel olarak, g\u00fc\u00e7l\u00fc sonu\u00e7lar bile k\u0131sa vadeli d\u00fc\u015f\u00fc\u015flere neden olabilir\u2014bu genellikle al\u0131m f\u0131rsatlar\u0131 sunar.<\/li> <li><strong>Portf\u00f6y Da\u011f\u0131l\u0131m\u0131:<\/strong> Amgen maruziyetinizi toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10'u ile s\u0131n\u0131rlay\u0131n. Biyoteknoloji, bir\u00e7ok di\u011fer sekt\u00f6re g\u00f6re daha y\u00fcksek volatilite ta\u015f\u0131r.<\/li> <li><strong>Esprili deneyimli tavsiyesi:<\/strong> \"AMGN ticareti yapmak bir biyoteknoloji dramas\u0131n\u0131 izlemek gibidir\u2014bazen bilim m\u00fckemmel \u00e7al\u0131\u015f\u0131r ama piyasa hala sahne korkusu ya\u015far. Sab\u0131r, hem molek\u00fclleri hem de ruh hali dalgalanmalar\u0131n\u0131 anlayanlar\u0131 \u00f6d\u00fcllendirir!\"<\/li> <\/ul> <h2>\u2705 Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve rekabet\u00e7i komisyon oranlar\u0131 sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n\u2014100 $ bile yolculu\u011funuza ba\u015flaman\u0131z\u0131 sa\u011flar<\/td><\/tr> <tr><td>3<\/td><td>\"AMGN\" aramas\u0131 yap\u0131n<\/td><td>Sadece \"Amgen\" de\u011fil, tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n; volatil d\u00f6nemlerde piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>\u00dccretleri ve emir detaylar\u0131n\u0131 son kez kontrol edin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, piyasaya giri\u015fin daha az korkutucu olmas\u0131n\u0131 sa\u011flayan birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum depozito miktar\u0131 5 $<\/strong> \u2014 Bu inan\u0131lmaz d\u00fc\u015f\u00fck bariyer, piyasalar\u0131 \u00f6\u011frenirken stratejileri minimum riskle test etmenizi sa\u011flar.<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama s\u00fcreci<\/strong> \u2014 Tek bir belge ile 1 dakikal\u0131k KYC sayesinde, onay i\u00e7in g\u00fcnlerce beklemek yerine hemen i\u015flem yapmaya ba\u015flayabilirsiniz.<\/li> <li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> \u2014 Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100'den fazla y\u00f6ntemle karlar\u0131n\u0131za eri\u015fimde esneklik sunar.<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve bu eri\u015filebilirlik \u00f6zellikleri, k\u00fc\u00e7\u00fck ba\u015flay\u0131p g\u00fcven ve deneyim kazanmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Amgen: Biyoteknolojinin Sabit Devi<\/h2> <p>Amgen, biyoteknoloji end\u00fcstrisinin bir dire\u011fi olarak, gelir baz\u0131nda en b\u00fcy\u00fck 18. biyomedikal \u015firket aras\u0131nda yer almakta ve Fortune 500 ile Forbes Global 2000 listelerinde konumunu korumaktad\u0131r. \u015eirketin Dow Jones Industrial Average ve Nasdaq-100 Endekslerine dahil edilmesi, piyasa genelindeki \u00f6nemini vurgulamaktad\u0131r.<\/p> <p>Mali g\u00f6stergelerinin \u00f6tesinde, Amgen yakla\u015f\u0131k 100 \u00fclkede faaliyet g\u00f6stermekte ve 28.000'den fazla \u00e7al\u0131\u015fan\u0131yla d\u00f6rt terap\u00f6tik alanda 40'tan fazla ila\u00e7 geli\u015ftirmektedir: genel t\u0131p, nadir hastal\u0131klar, inflamasyon ve onkoloji. Yakla\u015f\u0131m\u0131, insan geneti\u011finin derinlemesine anla\u015f\u0131lmas\u0131 ile geli\u015fmi\u015f protein m\u00fchendisli\u011fi ve yapay zeka yeteneklerini birle\u015ftirmektedir.<\/p> <p><strong>2025 i\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek:<\/strong> Amgen bu y\u0131l 45. y\u0131l\u0131n\u0131 kutlarken, biyoteknoloji end\u00fcstrisini do\u011furan \u015firket, ara\u015ft\u0131rmac\u0131lar\u0131n onlarca y\u0131l s\u00fcrecek genetik verileri manuel olarak i\u015flemelerini gerektiren s\u00fcre\u00e7leri yapay zeka ile analiz ediyor\u2014bu, hem \u015firketin hem de sekt\u00f6r\u00fcn Thousand Oaks, Kaliforniya'daki ilk g\u00fcnlerinden bu yana ne kadar ilerledi\u011finin bir g\u00f6stergesidir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Amgen Hisse Analizi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla Amgen Inc. (AMGN), NASDAQ borsas\u0131nda <strong>295,55 $<\/strong> seviyesinden i\u015flem g\u00f6rmektedir. Bu fiyat, hisse senedinin kazan\u00e7 sonras\u0131 volatiliteyi y\u00f6netirken g\u00fc\u00e7l\u00fc temel performans\u0131n\u0131 s\u00fcrd\u00fcrd\u00fc\u011f\u00fc kritik bir an\u0131 temsil ediyor.<\/p>\n<p><strong>Takviminize not edin: 29 Ekim 2025 kesinlikle kritik.<\/strong> Amgen, bu tarihte piyasa kapan\u0131\u015f\u0131ndan sonra 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar deneyimli yat\u0131r\u0131mc\u0131lar\u0131n yararlanabilece\u011fi \u00f6nemli fiyat hareketleri yaratm\u0131\u015ft\u0131r.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 AMGN Hissesini Nas\u0131l Etkiler?<\/h3>\n<p>5 A\u011fustos 2025&#8217;teki en son kazan\u00e7 a\u00e7\u0131klamas\u0131 m\u00fckemmel bir \u00f6rnek sunuyor. Hisse ba\u015f\u0131na 6,02 $ kazan\u00e7 (5,28 $ konsens\u00fcse kar\u015f\u0131) ve %9,4 gelir art\u0131\u015f\u0131 ile 9,18 milyar $ gelir elde edilmesine ra\u011fmen, hisse senedi a\u00e7\u0131klama sonras\u0131 <strong>%5,1<\/strong> d\u00fc\u015ft\u00fc. Bu, g\u00fc\u00e7l\u00fc temel performans\u0131n bile pozitif fiyat hareketini garanti etmedi\u011fini; piyasa duyarl\u0131l\u0131\u011f\u0131 ve rehberli\u011fin genellikle daha b\u00fcy\u00fck rol oynad\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>\n<p>Tarihsel kazan\u00e7 tepkileri bize \u015funlar\u0131 s\u00f6yl\u00fcyor:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Beklenen Hareket<\/th>\n<th>Ger\u00e7ekle\u015fen Hareket<\/th>\n<th>Sonu\u00e7<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>5 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>\u00b1%4,6<\/td>\n<td>-%5,1<\/td>\n<td>Tahminleri a\u015ft\u0131 ama d\u00fc\u015ft\u00fc<\/td>\n<\/tr>\n<tr>\n<td>\u00d6nceki \u00c7eyrek<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>Yok<\/td>\n<td>%17,79 s\u00fcrpriz<\/td>\n<td>\u00d6nemli pozitif tepki<\/td>\n<\/tr>\n<tr>\n<td>Tarihsel Ortalama<\/td>\n<td>\u00c7e\u015fitli<\/td>\n<td>\u00b1%4-5<\/td>\n<td>\u00c7ok de\u011fi\u015fken<\/td>\n<td>Temellere ra\u011fmen \u00f6ng\u00f6r\u00fclemez<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Model, Amgen&#8217;in kazan\u00e7 tepkilerinin tahmin edilmesinin zorlu\u011funu g\u00f6steriyor. Opsiyon piyasalar\u0131 genellikle %4-5 civar\u0131nda hareket fiyatlar, ancak ger\u00e7ek sonu\u00e7lar her iki y\u00f6nde de \u00f6nemli sapmalar g\u00f6sterebilir.<\/p>\n<h3>6 Ayl\u0131k Fiyat Seyri ve Trend Analizi<\/h3>\n<p>Amgen, son alt\u0131 ayda \u00f6nemli volatilite ya\u015fad\u0131 ve vah\u015fi dalgalanmalara ra\u011fmen toplamda <strong>%5,51 kazan\u00e7<\/strong> sa\u011flad\u0131. Hisse 6 Ocak 2025&#8217;te <strong>257,05 $<\/strong> dip seviyesine ula\u015ft\u0131, ard\u0131ndan 10 Mart 2025&#8217;te <strong>335,88 $<\/strong> zirveye \u00e7\u0131kt\u0131\u2014dipten zirveye <strong>%30,7&#8217;lik<\/strong> ola\u011fan\u00fcst\u00fc bir dalgalanma.<\/p>\n<p>\u015eu anki 295,55 $ fiyat\u0131 hisseyi konumland\u0131r\u0131yor:<\/p>\n<ul>\n<li><strong>%12,9 alt\u0131nda<\/strong> alt\u0131 ayl\u0131k zirvesinin<\/li>\n<li><strong>%13,9 \u00fczerinde<\/strong> alt\u0131 ayl\u0131k dip seviyesinin<\/li>\n<li>52 haftal\u0131k ortalama olan 296,54 $ seviyesinin biraz alt\u0131nda<\/li>\n<\/ul>\n<p>Son i\u015flem paterni, g\u00fc\u00e7l\u00fc \u00e7eyrek sonu\u00e7lar\u0131na ra\u011fmen devam eden belirsizli\u011fi g\u00f6stererek fiyatlar\u0131n A\u011fustos ortas\u0131nda 289-296 $ aras\u0131nda hareket etti\u011fini ortaya koyuyor.<\/p>\n<h3>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h3>\n<p>Mevcut analist konsens\u00fcs\u00fc ve \u00fcr\u00fcn hatt\u0131 geli\u015fmelerine dayanarak beklentiler \u015funlard\u0131r:<\/p>\n<p><strong>2025 Y\u0131l Sonu Hedefi: 340-345 $<\/strong> (mevcut fiyata g\u00f6re %15-17 y\u00fckseli\u015f)<br \/> Analistler, 2025 ortalama fiyat hedefini yakla\u015f\u0131k 340,02 $ olarak \u00f6ng\u00f6r\u00fcyor, en y\u00fcksek hedefler ise 385,98 $ seviyesinde. G\u00fc\u00e7l\u00fc 2. \u00e7eyrek sonu\u00e7lar\u0131 ve 35-36 milyar $ gelir i\u00e7in y\u00fckseltilmi\u015f tam y\u0131l rehberli\u011fi bu iyimser g\u00f6r\u00fcn\u00fcm\u00fc destekliyor.<\/p>\n<p><strong>2026 Tahmini: 360-380 $<\/strong> (\u0131l\u0131ml\u0131 b\u00fcy\u00fcme devam ediyor)<br \/> MariTide obezite ilac\u0131 Faz 3 denemelerinde ilerledik\u00e7e ve yeni endikasyonlar kabul g\u00f6rd\u00fck\u00e7e istikrarl\u0131 bir de\u011fer art\u0131\u015f\u0131 bekleniyor.<\/p>\n<p><strong>2028 Projeksiyonu: 380-420 $<\/strong> (\u00dcr\u00fcn hatt\u0131 olgunla\u015fmas\u0131 kar\u015f\u0131l\u0131\u011f\u0131n\u0131 veriyor)<br \/> 2028 y\u0131l\u0131na kadar bir\u00e7ok \u00fcr\u00fcn ticarile\u015fmi\u015f olacak ve bu, miras \u00fcr\u00fcnlerin \u00f6tesinde s\u00fcrd\u00fcr\u00fclebilir gelir art\u0131\u015f\u0131 sa\u011flayacak.<\/p>\n<p><strong>2030 Uzun Vadeli G\u00f6r\u00fcn\u00fcm: 390-450 $<\/strong> (S\u00fcrd\u00fcr\u00fclebilir b\u00fcy\u00fcme e\u011filimi)<br \/> Uzun vadeli modeller, Amgen&#8217;in 2030&#8217;da 394 $ ve \u00fczeri seviyelere ula\u015faca\u011f\u0131n\u0131 \u00f6ng\u00f6r\u00fcyor; bu muhafazakar ama istikrarl\u0131 bir de\u011fer art\u0131\u015f\u0131n\u0131 temsil ediyor.<\/p>\n<p><strong>Sonu\u00e7: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in AL, k\u0131sa vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in BEKLE.<\/strong> Mevcut d\u00fc\u015f\u00fc\u015f, 2-3 y\u0131ll\u0131k ufku olanlar i\u00e7in cazip bir giri\u015f noktas\u0131 sunuyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2>\n<h3>Her Yat\u0131r\u0131mc\u0131n\u0131n Dikkate Almas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Patent U\u00e7urumu Endi\u015feleri:<\/strong> Amgen&#8217;in en b\u00fcy\u00fck \u00fc\u00e7 \u00fcr\u00fcn\u00fc gelirlerin %55&#8217;ini olu\u015fturuyor ve bu \u00fcr\u00fcnlerin patentleri sona ermek \u00fczere, bu da sat\u0131\u015flar\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir. T\u00fcm ila\u00e7 sekt\u00f6r\u00fc, 2030&#8217;a kadar patent sona ermesi nedeniyle 300 milyar $ \u00fczerinde sat\u0131\u015f riskiyle kar\u015f\u0131 kar\u015f\u0131ya.<\/li>\n<li><strong>Reg\u00fclasyon Zorluklar\u0131:<\/strong> ABD Enflasyon Azaltma Yasas\u0131, 2039&#8217;a kadar ila\u00e7 gelirlerinde %31 azalma ve 135 daha az yeni ila\u00e7 onay\u0131 \u00f6ng\u00f6r\u00fcyor. Bu, ila\u00e7 geli\u015ftirme ekonomisini temelden de\u011fi\u015ftiriyor.<\/li>\n<li><strong>Rekabet Bask\u0131s\u0131:<\/strong> Ya\u015fam bilimleri y\u00f6neticilerinin %37&#8217;si, 2025 i\u00e7in jenerik ve biyobenzer rekabetini en b\u00fcy\u00fck endi\u015fe olarak g\u00f6r\u00fcyor. Amgen&#8217;in biyolojik \u00fcr\u00fcnleri, patentlerin sona ermesiyle artan rekabetle kar\u015f\u0131 kar\u015f\u0131ya.<\/li>\n<li><strong>Ekonomik K\u0131r\u0131lganl\u0131k:<\/strong> 2008 benzeri ciddi bir ekonomik kriz, Amgen&#8217;in rekabet avantajlar\u0131na ra\u011fmen gelir ve k\u00e2rlar\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir.<\/li>\n<\/ul>\n<h3>2025 B\u00fcy\u00fcmesi \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>MariTide At\u0131l\u0131m\u0131:<\/strong> Obezite ilac\u0131, kat\u0131l\u0131mc\u0131lar\u0131n %20&#8217;ye varan kilo kayb\u0131 ya\u015fad\u0131\u011f\u0131n\u0131 ve 52 haftada plato yapmad\u0131\u011f\u0131n\u0131 g\u00f6sterdi; ayl\u0131k dozlama potansiyeli tedavi devaml\u0131l\u0131\u011f\u0131n\u0131 devrim niteli\u011finde de\u011fi\u015ftirebilir.<\/li>\n<li><strong>G\u00fc\u00e7l\u00fc 2. \u00c7eyrek Performans\u0131:<\/strong> Toplam gelirler %9 artarak 9,2 milyar $ oldu, \u00fcr\u00fcn sat\u0131\u015flar\u0131 %9 ve hacim b\u00fcy\u00fcmesi %13 artt\u0131. On be\u015f \u00fcr\u00fcn \u00e7ift haneli sat\u0131\u015f b\u00fcy\u00fcmesi sa\u011flad\u0131.<\/li>\n<li><strong>\u00c7oklu Onaylar:<\/strong> IMDELLTRA ABD&#8217;de ilk onay\u0131n\u0131 ald\u0131 ve \u00f6l\u00fcm riskini %40 azaltt\u0131, TEPEZZA Avrupa onay\u0131 ald\u0131, UPLIZNA y\u0131ll\u0131k %91 b\u00fcy\u00fcme g\u00f6sterdi.<\/li>\n<li><strong>Y\u00fckseltilmi\u015f Rehberlik:<\/strong> Y\u00f6netim, 2025 tam y\u0131l gelir rehberli\u011fini 35-36 milyar $ ve GAAP d\u0131\u015f\u0131 hisse ba\u015f\u0131 kazanc\u0131 20,21-21,30 $ olarak art\u0131rd\u0131, bu da uygulama konusundaki g\u00fcveni g\u00f6steriyor.<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ul>\n<li><strong>Stratejik Giri\u015f Noktalar\u0131:<\/strong> Dolar maliyeti ortalamas\u0131 kullan\u0131n\u2014m\u00fckemmel giri\u015f zaman\u0131n\u0131 yakalamaya \u00e7al\u0131\u015fmak yerine haftal\u0131k sabit miktarlarda yat\u0131r\u0131m yap\u0131n. Amgen&#8217;in volatilitesi zamanlamay\u0131 \u00e7ok zorla\u015ft\u0131r\u0131yor.<\/li>\n<li><strong>Kazan\u00e7 Oynunu Planlay\u0131n:<\/strong> 29 Ekim kazan\u00e7lar\u0131 i\u00e7in uyar\u0131lar kurun. Tarihsel olarak, g\u00fc\u00e7l\u00fc sonu\u00e7lar bile k\u0131sa vadeli d\u00fc\u015f\u00fc\u015flere neden olabilir\u2014bu genellikle al\u0131m f\u0131rsatlar\u0131 sunar.<\/li>\n<li><strong>Portf\u00f6y Da\u011f\u0131l\u0131m\u0131:<\/strong> Amgen maruziyetinizi toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10&#8217;u ile s\u0131n\u0131rlay\u0131n. Biyoteknoloji, bir\u00e7ok di\u011fer sekt\u00f6re g\u00f6re daha y\u00fcksek volatilite ta\u015f\u0131r.<\/li>\n<li><strong>Esprili deneyimli tavsiyesi:<\/strong> &#8220;AMGN ticareti yapmak bir biyoteknoloji dramas\u0131n\u0131 izlemek gibidir\u2014bazen bilim m\u00fckemmel \u00e7al\u0131\u015f\u0131r ama piyasa hala sahne korkusu ya\u015far. Sab\u0131r, hem molek\u00fclleri hem de ruh hali dalgalanmalar\u0131n\u0131 anlayanlar\u0131 \u00f6d\u00fcllendirir!&#8221;<\/li>\n<\/ul>\n<h2>\u2705 Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve rekabet\u00e7i komisyon oranlar\u0131 sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n\u2014100 $ bile yolculu\u011funuza ba\u015flaman\u0131z\u0131 sa\u011flar<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;AMGN&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Sadece &#8220;Amgen&#8221; de\u011fil, tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n; volatil d\u00f6nemlerde piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>\u00dccretleri ve emir detaylar\u0131n\u0131 son kez kontrol edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, piyasaya giri\u015fin daha az korkutucu olmas\u0131n\u0131 sa\u011flayan birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito miktar\u0131 5 $<\/strong> \u2014 Bu inan\u0131lmaz d\u00fc\u015f\u00fck bariyer, piyasalar\u0131 \u00f6\u011frenirken stratejileri minimum riskle test etmenizi sa\u011flar.<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama s\u00fcreci<\/strong> \u2014 Tek bir belge ile 1 dakikal\u0131k KYC sayesinde, onay i\u00e7in g\u00fcnlerce beklemek yerine hemen i\u015flem yapmaya ba\u015flayabilirsiniz.<\/li>\n<li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> \u2014 Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100&#8217;den fazla y\u00f6ntemle karlar\u0131n\u0131za eri\u015fimde esneklik sunar.<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve bu eri\u015filebilirlik \u00f6zellikleri, k\u00fc\u00e7\u00fck ba\u015flay\u0131p g\u00fcven ve deneyim kazanmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Amgen: Biyoteknolojinin Sabit Devi<\/h2>\n<p>Amgen, biyoteknoloji end\u00fcstrisinin bir dire\u011fi olarak, gelir baz\u0131nda en b\u00fcy\u00fck 18. biyomedikal \u015firket aras\u0131nda yer almakta ve Fortune 500 ile Forbes Global 2000 listelerinde konumunu korumaktad\u0131r. \u015eirketin Dow Jones Industrial Average ve Nasdaq-100 Endekslerine dahil edilmesi, piyasa genelindeki \u00f6nemini vurgulamaktad\u0131r.<\/p>\n<p>Mali g\u00f6stergelerinin \u00f6tesinde, Amgen yakla\u015f\u0131k 100 \u00fclkede faaliyet g\u00f6stermekte ve 28.000&#8217;den fazla \u00e7al\u0131\u015fan\u0131yla d\u00f6rt terap\u00f6tik alanda 40&#8217;tan fazla ila\u00e7 geli\u015ftirmektedir: genel t\u0131p, nadir hastal\u0131klar, inflamasyon ve onkoloji. Yakla\u015f\u0131m\u0131, insan geneti\u011finin derinlemesine anla\u015f\u0131lmas\u0131 ile geli\u015fmi\u015f protein m\u00fchendisli\u011fi ve yapay zeka yeteneklerini birle\u015ftirmektedir.<\/p>\n<p><strong>2025 i\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek:<\/strong> Amgen bu y\u0131l 45. y\u0131l\u0131n\u0131 kutlarken, biyoteknoloji end\u00fcstrisini do\u011furan \u015firket, ara\u015ft\u0131rmac\u0131lar\u0131n onlarca y\u0131l s\u00fcrecek genetik verileri manuel olarak i\u015flemelerini gerektiren s\u00fcre\u00e7leri yapay zeka ile analiz ediyor\u2014bu, hem \u015firketin hem de sekt\u00f6r\u00fcn Thousand Oaks, Kaliforniya&#8217;daki ilk g\u00fcnlerinden bu yana ne kadar ilerledi\u011finin bir g\u00f6stergesidir.<\/p>\n"},"faq":[{"question":"Amgen hisseleri nereden al\u0131nabilir?","answer":"Amgen hisseleri NASDAQ borsas\u0131nda AMGN sembol\u00fc ile i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Amgen hisseleri i\u00e7in 2025 fiyat hedefi nedir?","answer":"Analistlerin 2025 y\u0131l sonu fiyat hedefi 340-345 $ aral\u0131\u011f\u0131nda olup, mevcut fiyata g\u00f6re %15-17 civar\u0131nda bir y\u00fckseli\u015f potansiyeli \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Amgen hisseleri i\u00e7in temel riskler nelerdir?","answer":"Patent sona erme riski, reg\u00fclasyon zorluklar\u0131, artan rekabet ve ekonomik krizler Amgen hisseleri i\u00e7in ba\u015fl\u0131ca riskler aras\u0131nda yer almaktad\u0131r."},{"question":"Yeni ba\u015flayanlar Amgen hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Dolar maliyeti ortalamas\u0131 y\u00f6ntemiyle d\u00fczenli ve sabit miktarlarda yat\u0131r\u0131m yapmak, kazan\u00e7 raporlar\u0131 \u00f6ncesi uyar\u0131lar kurmak ve portf\u00f6yde %5-10 aras\u0131 bir pay ay\u0131rmak \u00f6nerilir."},{"question":"Pocket Option platformunun avantajlar\u0131 nelerdir?","answer":"D\u00fc\u015f\u00fck minimum depozito (5 $), h\u0131zl\u0131 do\u011frulama s\u00fcreci ve \u00e7ok \u00e7e\u015fitli para \u00e7ekme se\u00e7enekleri ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in eri\u015filebilir ve kullan\u0131c\u0131 dostu bir platformdur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Amgen hisseleri nereden al\u0131nabilir?","answer":"Amgen hisseleri NASDAQ borsas\u0131nda AMGN sembol\u00fc ile i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Amgen hisseleri i\u00e7in 2025 fiyat hedefi nedir?","answer":"Analistlerin 2025 y\u0131l sonu fiyat hedefi 340-345 $ aral\u0131\u011f\u0131nda olup, mevcut fiyata g\u00f6re %15-17 civar\u0131nda bir y\u00fckseli\u015f potansiyeli \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Amgen hisseleri i\u00e7in temel riskler nelerdir?","answer":"Patent sona erme riski, reg\u00fclasyon zorluklar\u0131, artan rekabet ve ekonomik krizler Amgen hisseleri i\u00e7in ba\u015fl\u0131ca riskler aras\u0131nda yer almaktad\u0131r."},{"question":"Yeni ba\u015flayanlar Amgen hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Dolar maliyeti ortalamas\u0131 y\u00f6ntemiyle d\u00fczenli ve sabit miktarlarda yat\u0131r\u0131m yapmak, kazan\u00e7 raporlar\u0131 \u00f6ncesi uyar\u0131lar kurmak ve portf\u00f6yde %5-10 aras\u0131 bir pay ay\u0131rmak \u00f6nerilir."},{"question":"Pocket Option platformunun avantajlar\u0131 nelerdir?","answer":"D\u00fc\u015f\u00fck minimum depozito (5 $), h\u0131zl\u0131 do\u011frulama s\u00fcreci ve \u00e7ok \u00e7e\u015fitli para \u00e7ekme se\u00e7enekleri ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in eri\u015filebilir ve kullan\u0131c\u0131 dostu bir platformdur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amgen Inc. (AMGN) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amgen Inc. (AMGN) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T11:55:52+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Amgen Inc. (AMGN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T11:55:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/\",\"name\":\"Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amgen Inc. (AMGN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"datePublished\":\"2025-08-20T11:55:52+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Amgen Inc. (AMGN) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amgen Inc. (AMGN) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/","og_locale":"tr_TR","og_type":"article","og_title":"Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amgen Inc. (AMGN) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T11:55:52+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Amgen Inc. (AMGN) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T11:55:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/","name":"Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Amgen Inc. (AMGN) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","datePublished":"2025-08-20T11:55:52+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-amgen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Amgen Inc. (AMGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Amgen Inc. (AMGN) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":340582,"slug":"how-to-buy-amgen","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Amgen Inc. (AMGN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Amgen Inc. (AMGN)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-amgen\/"},"pt_AA":{"locale":"pt_AA","id":340578,"slug":"how-to-buy-amgen","post_title":"Como comprar a\u00e7\u00f5es da Amgen Inc. (AMGN) - Investimento em a\u00e7\u00f5es da Amgen Inc. (AMGN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-amgen\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340580","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=340580"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340580\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334036"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=340580"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=340580"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=340580"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}